Skip to main content

and
  1. No Access

    Article

    T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect

    Thirty-eight patients with hematological malignancies, received T cell-depleted marrow transplants (BMT) and cyclosporine to prevent acute graft-versus-host disease (aGVHD), followed by delayed add-back of don...

    AJ Barrett, D Mavroudis, J Tisdale, J Molldrem, E Clave in Bone Marrow Transplantation (1998)

  2. No Access

    Article

    T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia

    To increase the stem cell content of T cell-depleted bone marrow transplants (BMT), we treated 12 patients with hematological malignancies with BMT from HLA-identical sibling donors given G-CSF 10 μg/kg/day fo...

    DA Mavroudis, EJ Read, J Molldrem, A Raptis, M Plante in Bone Marrow Transplantation (1998)